Created at Source Raw Value Validated value
June 25, 2024, noon usa

1. patient in palliative care 2. severe covid-19 disease (spo2 ≤ 94% with o2 ≥ 5 l/min) 3. contra-indication to imatinib 4. therapy with warfarin (heparin allowed) 5. stage ii to iv congestive heart failure (chf) as determined by the new york heart association (nyha) 6. peripheral edema grade \> 2 7. known hbv, hbc or hiv infection 8. known hepatic failure 9. patient under legal protection

1. patient in palliative care 2. severe covid-19 disease (spo2 ≤ 94% with o2 ≥ 5 l/min) 3. contra-indication to imatinib 4. therapy with warfarin (heparin allowed) 5. stage ii to iv congestive heart failure (chf) as determined by the new york heart association (nyha) 6. peripheral edema grade \> 2 7. known hbv, hbc or hiv infection 8. known hepatic failure 9. patient under legal protection

Nov. 16, 2021, 6:30 p.m. usa

patient in palliative care severe covid-19 disease (spo2 ≤ 94% with o2 ≥ 5 l/min) contra-indication to imatinib therapy with warfarin (heparin allowed) stage ii to iv congestive heart failure (chf) as determined by the new york heart association (nyha) peripheral edema grade > 2 known hbv, hbc or hiv infection known hepatic failure patient under legal protection

patient in palliative care severe covid-19 disease (spo2 ≤ 94% with o2 ≥ 5 l/min) contra-indication to imatinib therapy with warfarin (heparin allowed) stage ii to iv congestive heart failure (chf) as determined by the new york heart association (nyha) peripheral edema grade > 2 known hbv, hbc or hiv infection known hepatic failure patient under legal protection

Oct. 26, 2020, 11:31 p.m. usa

1. patient in palliative care 2. severe covid-19 disease (spo2 ≤ 94% with o2 ≥ 5 l/min) 3. contra-indication to imatinib 4. therapy with warfarin (heparin allowed) 5. stage ii to iv congestive heart failure (chf) as determined by the new york heart association (nyha) 6. peripheral edema grade > 2 7. known hbv, hbc or hiv infection 8. known hepatic failure 9. patient under legal protection

1. patient in palliative care 2. severe covid-19 disease (spo2 ≤ 94% with o2 ≥ 5 l/min) 3. contra-indication to imatinib 4. therapy with warfarin (heparin allowed) 5. stage ii to iv congestive heart failure (chf) as determined by the new york heart association (nyha) 6. peripheral edema grade > 2 7. known hbv, hbc or hiv infection 8. known hepatic failure 9. patient under legal protection